Technology | Nuclear Imaging | June 09, 2016

Siemens Healthineers Debuts Mobile PET/CT System, Molecular Imaging Software at SNMMI ‘16

Latest version of syngo.via for Molecular Imaging adds SPECT capabilities; Biograph Horizon PET/CT now has mobile configuration

Siemens Healthineers, SNMMI '16, molecular imaging, syngo.via, Biograph Horizon PET/CT, mobile configuration

June 9, 2016 — At the 2016 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), Siemens Healthineers will highlight a new release of its syngo.via for Molecular Imaging software. The company will also feature a new mobile configuration of its Biograph Horizon positron emission tomography/computed tomography (PET/CT) system at the meeting, June 11-15 in San Diego.

The new version of the syngo.via for Molecular Imaging software enables preprocessing, reading and reporting for PET and, for the first time, single photon emission computed tomography (SPECT). This enables physicians to use the intuitive user interface to allow for synergies across departments.

The new iteration of syngo.via for Molecular Imaging offers four new features. For SPECT, organ processing for nuclear medicine helps physicians visualize and quantify the physiological characteristics of organs such as the lungs, kidneys and stomach. For PET, the Molecular Tumor Volume (MTV) and Total Lesion Glycolysis (TLG) features together enable physicians to measure the standardized metabolic activity of the entire tumor mass, potentially improving the preoperative identification of high-risk patients and the prognostic value in predicting overall survival. Hybrid gating 4-D visualization of PET and CT supports therapy planning and delivery.

And syngo.via MI Workplace – the company’s cost-effective, scalable configuration of syngo.via for Molecular Imaging – is designed to bolster the performance of PET and SPECT scanners. In addition to image processing, syngo.via MI Workplace may increase diagnostic confidence by quantifying disease parameters in a wide range of clinical areas. Available with the Biograph Horizon PET/CT system and with all Symbia SPECT and SPECT/CT systems, syngo.via MI Workplace may increase a facility’s clinical capabilities and can be expanded to accommodate an ever-evolving exam mix.

Siemens Healthineers also debuts the mobile configuration of its recently introduced Biograph Horizon PET/CT system, which delivers high-end functionality at an attractive total cost of ownership. This new mobile-ready version of Biograph Horizon is intended for cost-conscious healthcare facilities that do not yet possess the patient volume to support installation of a fixed PET/CT. The mobile configuration also may be ideal for consolidated health systems looking to tailor their imaging delivery strategy in diverse service areas.

Migrating technology from the company’s premium Biograph family of PET/CT systems to help providers address more clinical indications in oncology, neurology and cardiology while also introducing new efficiencies and cost savings, Biograph Horizon enables physicians to visualize small lesions early. The system’s 4 mm lutetium orthosilicate (LSO) crystals scintillate faster and boast a higher light output than commonly used bismuth germanate oxide (BGO) crystals, yielding high image resolution and better image quality as well as enabling Time-of-Flight acquisition. By receiving more detailed patient data earlier, clinicians may stage disease and evaluate therapy response more accurately, contributing to more effective care pathways.

With the addition of the mobile version of Biograph Horizon, the entire line of Biograph PET/CT systems from Siemens Healthineers – including Biograph mCT and Biograph mCT Flow – is available in mobile as well as fixed configurations.

For more information: www.healthcare.siemens.com

Related Content

This is 4MD’s cardiac nuclear imaging analysis software, shown here integrated with a ScImage cardiovascular information system (CVIS). Both companies displayed on the expo floor at ASNC 2019. The software creates a single page report seen here. PET perfusion imaging was a big topics at the conference. #ASNC #ASNC19 #ASNC2019

This is 4MD’s cardiac nuclear imaging analysis software, shown here integrated with a ScImage cardiovascular information system (CVIS). Both companies displayed on the expo floor at ASNC 2019. The software creates a single page report seen here. PET perfusion imaging was a big topic at the conference.

Feature | Nuclear Imaging | November 22, 2019 | Dave Fornell, Editor
There were a few key takeaways from the American Society of Nuclear Cardiology (ASNC) 2019 annual meeting in September...
Videos | Nuclear Imaging | November 07, 2019
American Society of Nuclear Cardiology (ASNC) President Rob Beanlands, M.D., shares a couple trends he sees in cardiac...
Videos | Nuclear Imaging | November 06, 2019
Doctor Robert Hendel explains some of the new cardiac radiotracers in the pipeline that were discussed in sessions at...
With the advent and optimization of nuclear scintigraphy protocols using bone-avid radiotracers, cardiac amyloidosis caused by transthyretin protein (ATTR) can now be diagnosed noninvasively without a costly tissue biopsy. The radiotracer 99mTc-pyrophosphate (99mTc-PYP) binds to deposited ATTR amyloid fibrils in the myocardium and can be visualized using planar and SPECT imaging. The image shows how SPECT allows the reader to distinguish between blood pool activity and radiotracer uptake.

With the advent and optimization of nuclear scintigraphy protocols using bone-avid radiotracers, cardiac amyloidosis caused by transthyretin protein (ATTR) can now be diagnosed noninvasively without a costly tissue biopsy. The radiotracer 99mTc-pyrophosphate (99mTc-PYP) binds to deposited ATTR amyloid fibrils in the myocardium and can be visualized using planar and SPECT imaging. This is Figure 2, showing how SPECT imaging allows the reader to distinguish between blood pool activity (ventricular cavity, etc) and myocardial activity and identify regional myocardial differences in radiotracer uptake.

Feature | Nuclear Imaging | July 22, 2019 | Christopher A. Hanson M.D., and Jamieson M. Bourque M.D., MHS
Cardiac amyloidosis is a highly morbid and underdiagnosed infiltrative cardiomyopathy that is characterized by the de
GE Healthcare Recalls Millennium Nuclear Medicine Systems
News | Nuclear Imaging | November 15, 2018
GE Healthcare announced it is recalling its Millennium Nuclear Medicine Systems due to an incident in which the the top...
Technology and Radionucleotide Development Will Fuel Mobile Gamma Camera Adoption
News | Nuclear Imaging | September 27, 2018
Advancements in healthcare technology, particularly in the surgery category, have led to an increasing adoption of...
Videos | Nuclear Imaging | August 21, 2018
Rami Doukky, M.D., professor of medicine, preventive medicine and radiology, and chief of the Division of Cardiology
ASNC Announces Keynote Speakers for 2018 Annual Scientific Session
News | Nuclear Imaging | August 08, 2018
August 8, 2018 — The American Society of Nuclear Cardiology’s (ASNC) Annual Scientific Session, ASNC2018, will kick o
Overlay Init